paul stuka  inspiremd inc  zoominfocom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates inspiremd announces appointment of paul stuka as chairman of the board employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       inspiremd announces appointment of paul stuka as chairman of the board tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs tel aviv israelmarketwired  june    inspiremd inc nyse mkt nspr nyse mkt nsprws inspiremd or the company a leader in embolic prevention systems eps  thrombus management technologies and neurovascular devices today announced that paul stuka who has served on the companys board of directors since  has been appointed chairman of the board replacing sol barer phd who is stepping down from the board due to conflicting professional commitments but will serve as a special advisor to the board mr stuka currently serves as the managing member of osiris partners llc an investment fund since  prior to forming osiris partners llc mr stuka was a managing director of longwood partners managing small cap institutional accounts in  mr stuka joined state street research and management as manager of its market neutral and mid cap growth funds from  to  mr stuka served as the general partner of stuka associates where he managed a us based investment partnership mr stuka began his career in  as an analyst at fidelity management and research as an analyst mr stuka followed a wide array of industries including healthcare energy transportation and lodging and gaming early in his career he became the assistant portfolio manager for three fidelity funds including the select healthcare fund which was recognized as the top performing fund in the united states for the fiveyear period ending december   james barry phd chief executive officer of inspiremd commented both the management team and the board are excited with the appointment of paul as our new chairman of the board paul not only brings over  years of capital markets experience which will be extremely valuable as we enter the next phase of our growth but he also knows our company well given his role as a director since  he has an impressive track record helping micro and smallcap companies navigate the capital markets and maximize shareholder value mr stuka commented i am honored to become chairman of inspiremd recent responses to our technology from key opinions leaders has been overwhelmingly positive and we look forward to capitalizing on this excitement as we rapidly grow our distribution network throughout the world first and foremost we are committed to maximizing value for shareholders by continued revenue growth careful management of our expenses and an eye on potential partnerships across our technology platform i would also like the thank sol barer for his tremendous contributions as chairman of the board his guidance and support over the years has been invaluable and we are grateful for his willingness to serve as a special advisor to the board dr barer concluded i remain confident in the outlook for the company although my current responsibilities preclude me from serving on the board i look forward to remaining an active advisor supporter and major shareholder of the company about inspiremd inc inspiremd seeks to utilize its proprietary micronet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization no reflow and major adverse cardiac events inspiremd intends to pursue applications of this micronet technology in coronary carotid cguard™ neurovascular and peripheral artery procedures inspiremds common stock is quoted on the nyse mkt under the ticker symbol nspr and certain warrants are quoted on the nyse mkt under the ticker symbol nsprws forwardlooking statements this press release contains forwardlooking statements such statements may be preceded by the words intends may will plans expects anticipates projects predicts estimates aims believes hopes potential or similar words forwardlooking statements are not guarantees of future performance are based on certain assumptions and are subject to various known and unknown risks and uncertainties many of which are beyond the companys control and cannot be predicted or quantified and consequently actual results may differ materially from those expressed or implied by such forwardlooking statements such risks and uncertainties include without limitation risks and uncertainties associated with i market acceptance of our existing and new products ii negative clinical trial results or lengthy product delays in key markets iii an inability to secure regulatory approvals for the sale of our products iv intense competition in the medical device industry from much larger multinational companies v product liability claims vi product malfunctions vii our limited manufacturing capabilities and reliance on subcontractors for assistance viii insufficient or inadequate reimbursement by governmental and other third party payers for our products ix our efforts to successfully obtain and maintain intellectual property protection covering our products which may not be successful x legislative or regulatory reform of the healthcare system in both the us and foreign jurisdictions xi our reliance on single suppliers for certain product components xii the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly dilutive or difficult to obtain and xiii the fact that we conduct business in multiple foreign jurisdictions exposing us to foreign currency exchange rate fluctuations logistical and communications challenges burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction more detailed information about the company and the risk factors that may affect the realization of forward looking statements is set forth in the companys filings with the securities and exchange commission sec including the companys annual report on form k and its quarterly reports on form q investors and security holders are urged to read these documents free of charge on the secs web site at httpwwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise investor contactsinspiremd inccraig shorechief financial officerphone  freeemail craigsinspiremdcom crescendo communications llcdavid waldmanphone  email nsprcrescendoircom read at biospacecom related news update  inspiremd announces listing of warrants on the nyse mkt controversial nantkwest ceo appointed to national health it advisory committee inspiremd announces closing of public offering of approximately  million founding ceo of editas medicine edit lands new gig at top biotech vc firm inspiremd appoints thomas kester to board of directors biogen biib loses yet another top exec inspiremd announces first two patients in hong kong successfully treated with cguard eps struggling mannkind mnkd replaces ceo inspiremd announces cguard embolic prevention system commercialization approval in russia meet the former twitter google goog execs that created a biotech to detect cancer earlier please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • inspiremd ltd   • biotechpharma  personnel                 robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates paul s stuka  founder  chief investment officer at osiris investment partners llc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink paul s stuka founder  chief investment officer at osiris investment partners llc overview in the news relationships paths career history boards  committees nonprofit donations  grants public holdings paul s stuka founder  chief investment officer at osiris investment partners llc overview age  born  notable companies osiris investment partners llc board seats  number of relationships this person is connected to  people in the news see more marketwired june   inspiremd announces appointment of paul stuka as chairman of the board relationships see details james barry president chief executive officer  director at inspiremd inc jay m eastman founder at caliber id inc larry michael hone chief executive officer  director at caliber id inc lyndia downie president  executive director at pine street inn inc john h mccarthy treasurer  director at pine street inn inc megan n gates member attorney at mintz levin cohn ferris glovsky and popeo pc steve kelley member board of directors at pine street inn inc susan tracy member board of directors at pine street inn inc lawrence battle former director at pine street inn inc rocco j maggiotto chief executive officer at pwrcierge llc see  more listings with relsci professional start my free trial ➤ see  more paths to paul s stuka paul s stuka you connections via relationship science paul s stuka sync your contacts to see how you can connect with paul s stuka start my free trial ➤ see more career history founder  chief investment officer current osiris investment partners llc osiris investment partners llc is a hedge fund manager located in boston principal  managing member   prior osiris partners llc   prior state street research  management co ssr combines bottomup stock selection with quantitative risk controlsthe asset allocation committee formulates the asset allocation strategy based upon the relative attractiveness variability and correlation between the equity and fixed income markets the committee reviews a wide range of factors that include forecasts of corporate earnings liquidity and an assessment of macroeconomic trends the committee formally reviews allocation targets on a monthly basisfor active equity management they combine bottomup stock selection based on comprehensive fundamental research with explicit sector weighting decisions and quantitative risk management teams manage portfoliosssr believes that fixed income security prices respond to economic fundamentals in predictable but not perfectly efficient ways they seek to identify opportunities created by these inefficiencies through fundamental research supported by quantitative risk controls general partner    stuka associates inc assistant portfolio manager   prior fidelity management  research co fidelity management  research cos fmr investment approach is based on a rigorous fundamental bottomup stock selection process the firm seeks to identify and invest in the stocks of companies with the potential for longterm capital appreciation or companies with hidden or unrealized valuefmr uses a wide variety of investment strategies in managing client assets including but not limited to investments in stocks and other equity securities stocks with growth or value characteristics bonds and other debt securities and repurchase agreements for those securities and real estate related investments the firm may participate in short sales margin transactions and option writing including covered options uncovered options or spreading strategies fmr invests in us and nonus issuers including issuers in emerging or frontier markets they invest in companies with small medium and large market capitalizations investments are allocated across different asset classes market sectors maturities countries and regions investments may be made in the securities of companies engaged in particular industries or market sectors and in a combination of underlying fidelity fundsmargin may be required in connection with certain client futures and options transactions or in connection with short sales fmr does not engage in the purchase of securities on margin except in connection with the clearance and settlement of securities transactionsfmr may engage in swap transactions and swaptions including interest rate total return and credit default written covered call options and futures transactions currency spot and forward trading and other currency related derivatives in addition fmr may engage in securities lending to parties such as brokerdealers or other institutions managing director prior longwood partners llc illinois boards  committees corporate boards ▾ independent director   current caliber id inc lucid inc is a medical technologies company that designs develops and markets innovative imaging solutions that shows tissue at the cellular level the company offers in vivo confocal microscopes designed specifically for imaging skin and other tissue its rapid cell id technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye the companys product includes vivascope vivascan vivanet and vivacam lucid was founded by jay m eastman on november   and is headquartered in andover ma chairman board of directors   current inspiremd inc inspiremd inc is a medical device company which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease its products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions the company was founded in  and is headquartered in tel aviv israel nonprofit boards ▾ director prior   pine street inn inc pine street inn inc provides programs and services for homeless individuals it offers a comprehensive range of services including permanent supportive housing job training and placement emergency shelter and street outreach the company was founded by paul sullivan in  and is headquartered in boston ma director prior hopefound inc hopefound is dedicated to preventing and ending homelessness among men and women by helping them to achieve selfsufficiency and to secure and maintain permanent housing treasurer tenure unconfirmed alzheimers association  massachusettsnew hampshire chapter the mission of the alzheimers association is to eliminate alzheimers disease through the advancement of research to provide and enhance care and support for all affected and to reduce the risk of dementia through the promotion of brain health nonprofit donations  grants     pan massachusetts challenge trust     the jimmy fund since its founding in  the jimmy fund has raised millions of dollars through thousands of grassroots efforts to help save lives and give hope to cancer patients everywhere     alzheimers association  massachusettsnew hampshire chapter the mission of the alzheimers association is to eliminate alzheimers disease through the advancement of research to provide and enhance care and support for all affected and to reduce the risk of dementia through the promotion of brain health     pan massachusetts challenge trust     the jimmy fund since its founding in  the jimmy fund has raised millions of dollars through thousands of grassroots efforts to help save lives and give hope to cancer patients everywhere see  more listings with relsci professional start my free trial ➤ see  more public holdings restricted data only for relsci professional users start my free trial ➤ see more other affiliations paul s stuka is affiliated with osiris investment partners llc osiris partners llc state street research  management co stuka associates inc fidelity management  research co longwood partners llc illinois caliber id inc inspiremd inc pine street inn inc hopefound inc alzheimers association  massachusettsnew hampshire chapter youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ paul stuka  inspiremd home  about  board of directors  paul stuka paul stuka mr stuka was named to the board of directors in august of  and serves as chairman of the audit committee mr stuka is a managing member of osiris partners and a year investment industry veteran prior to forming osiris partners he was a managing director of longwood partners managing small cap institutional accounts in  he joined state street research and management as manager of its market neutral and mid cap growth funds from  to  he served as the general partner of stuka associates where he managed a usbased investment partnership mr stuka began his career in  as an analyst at fidelity management and research as an analyst he followed a wide array of industries including healthcare energy transportation and lodging  gaming early in his career he became the assistant portfolio manager for three fidelity funds including the select healthcare fund which was recognized as the top performing fund in the us for the fiveyear period ending december   in  he became the original manager of the fidelity otc fund which was the secondbest performing us mutual fund for  appreciating  at the time of his departure in june  the fund had appreciated over  in  months and assets approached  billion during his career mr stuka has been featured in articles in the wall street journal barron’s the new york times and businessweek board of directors  inspiremd home  about  board of directors board of directors sol barer phd chairman of the board of directors dr barer is a biotechnology industry veteran and the founder and former chairman president coo and ceo of celgene he brings to inspiremd over  years of experience with publicly… isaac blech vice chairman of the board of directors isaac blech is one of the most successful private financiers in the biotechnology industry over the past thirty five years he founded and served on the board of numerous companies… james j barry president  chief executive officer dr barry has over  years of experience in the medical device industry prior to joining inspiremd he was the president and ceo of arsenal medical a life sciences company… michael berman mr berman is a successful entrepreneur within the medical device industry he joined scimed in  leading its marketing activities until its merger with boston scientific in  from … campbell rogers dr rogers currently serves as the chief medical officer of heartflow inc a private cardiovascular diagnostics company based in california prior to joining heartflow he was the chief scientific officer… paul stuka mr stuka was named to the board of directors in august of  and serves as chairman of the audit committee mr stuka is a managing member of osiris partners… thomas kester mr kester is chief financial officer of kester search group inc a private executive search firm specializing in sales force placement for medical dental and diagnostic device companies  he spent… inspiremd announces appointment of paul stuka as chairman of the boardhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballinspiremd announces appointment of paul stuka as chairman of the boardmarketwiredjune  reblogsharetweetsharetel aviv israelmarketwired  jun    inspiremd inc  nyse mkt  nspr   nyse mkt  nsprws  inspiremd or the company a leader in embolic prevention systems eps  thrombus management technologies and neurovascular devices today announced that paul stuka who has served on the companys board of directors since  has been appointed chairman of the board replacing sol barer phd who is stepping down from the board due to conflicting professional commitments but will serve as a special advisor to the boardmr stuka currently serves as the managing member of osiris partners llc an investment fund since  prior to forming osiris partners llc mr stuka was a managing director of longwood partners managing small cap institutional accounts in  mr stuka joined state street research and management as manager of its market neutral and mid cap growth funds from  to  mr stuka served as the general partner of stuka associates where he managed a us based investment partnership mr stuka began his career in  as an analyst at fidelity management and research as an analyst mr stuka followed a wide array of industries including healthcare energy transportation and lodging and gaming early in his career he became the assistant portfolio manager for three fidelity funds including the select healthcare fund which was recognized as the top performing fund in the united states for the fiveyear period ending december  james barry phd chief executive officer of inspiremd commented both the management team and the board are excited with the appointment of paul as our new chairman of the board paul not only brings over  years of capital markets experience which will be extremely valuable as we enter the next phase of our growth but he also knows our company well given his role as a director since  he has an impressive track record helping micro and smallcap companies navigate the capital markets and maximize shareholder valuemr stuka commented i am honored to become chairman of inspiremd recent responses to our technology from key opinions leaders has been overwhelmingly positive and we look forward to capitalizing on this excitement as we rapidly grow our distribution network throughout the world first and foremost we are committed to maximizing value for shareholders by continued revenue growth careful management of our expenses and an eye on potential partnerships across our technology platform i would also like the thank sol barer for his tremendous contributions as chairman of the board his guidance and support over the years has been invaluable and we are grateful for his willingness to serve as a special advisor to the boarddr barer concluded i remain confident in the outlook for the company although my current responsibilities preclude me from serving on the board i look forward to remaining an active advisor supporter and major shareholder of the companyabout inspiremd inc inspiremd seeks to utilize its proprietary micronet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization no reflow and major adverse cardiac eventsinspiremd intends to pursue applications of this micronet technology in coronary carotid cguard™ neurovascular and peripheral artery procedures inspiremds common stock is quoted on the nyse mkt under the ticker symbol nspr and certain warrants are quoted on the nyse mkt under the ticker symbol nsprwsforwardlooking statements this press release contains forwardlooking statements such statements may be preceded by the words intends may will plans expects anticipates projects predicts estimates aims believes hopes potential or similar words forwardlooking statements are not guarantees of future performance are based on certain assumptions and are subject to various known and unknown risks and uncertainties many of which are beyond the companys control and cannot be predicted or quantified and consequently actual results may differ materially from those expressed or implied by such forwardlooking statements such risks and uncertainties include without limitation risks and uncertainties associated with i market acceptance of our existing and new products ii negative clinical trial results or lengthy product delays in key markets iii an inability to secure regulatory approvals for the sale of our products iv intense competition in the medical device industry from much larger multinational companies v product liability claims vi product malfunctions vii our limited manufacturing capabilities and reliance on subcontractors for assistance viii insufficient or inadequate reimbursement by governmental and other third party payers for our products ix our efforts to successfully obtain and maintain intellectual property protection covering our products which may not be successful x legislative or regulatory reform of the healthcare system in both the us and foreign jurisdictions xi our reliance on single suppliers for certain product components xii the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly dilutive or difficult to obtain and xiii the fact that we conduct business in multiple foreign jurisdictions exposing us to foreign currency exchange rate fluctuations logistical and communications challenges burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction more detailed information about the company and the risk factors that may affect the realization of forward looking statements is set forth in the companys filings with the securities and exchange commission sec including the companys annual report on form k and its quarterly reports on form q investors and security holders are urged to read these documents free of charge on the secs web site at httpwwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwisereblogsharetweetsharerecently viewedyour list is emptywhat to read nextloan move looms as bayern plan to keep sanchesomnisportthis will be in everyones household by banyan hillsponsoredmartin shkrelis lawyer says former drug company chairman tried to seduce the pharma brocnbcjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchwill phillips  psx disappoint this earnings seasonzacksengineer finds pattern makes millions in stocksmoney morningsponsoredunder armour uaa to report q earnings what lies aheadzackstrump names john kelly new chief of staff reince priebus outcnbcthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderzuckerberg wifes ambitious secret finally exposedunewzmesponsorednorth korea nd icbm test puts much of us in range expertsassociated presschevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weekdiscover it  out of  avg by k customersdiscover cardsponsoredthe real reason overseas manufacturing is coming to americayahoo financehere are the us targets north korea most likely wants to nukebusiness insiderdonald trump tweetrages after john mccain kills obamacare skinny repealstan let trump rage mccain you did the right thingjoin the conversation  k